These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30419493)

  • 1. Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A
    de Gaetano M; Butler E; Gahan K; Zanetti A; Marai M; Chen J; Cacace A; Hams E; Maingot C; McLoughlin A; Brennan E; Leroy X; Loscher CE; Fallon P; Perretti M; Godson C; Guiry PJ
    Eur J Med Chem; 2019 Jan; 162():80-108. PubMed ID: 30419493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A
    de Gaetano M; Tighe C; Gahan K; Zanetti A; Chen J; Newson J; Cacace A; Marai M; Gaffney A; Brennan E; Kantharidis P; Cooper ME; Leroy X; Perretti M; Gilroy D; Godson C; Guiry PJ
    J Med Chem; 2021 Jul; 64(13):9193-9216. PubMed ID: 34138563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation.
    Galvão I; Melo EM; de Oliveira VLS; Vago JP; Queiroz-Junior C; de Gaetano M; Brennan E; Gahan K; Guiry PJ; Godson C; Teixeira MM
    Pharmacol Res; 2021 Mar; 165():105445. PubMed ID: 33493655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
    Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
    FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of the formyl peptide receptor 2 gene.
    Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
    Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of Bicyclo[1.1.1]pentane-Containing Aromatic Lipoxin A
    Owen B; de Gaetano M; Gaffney A; Godson C; Guiry PJ
    Org Lett; 2022 Aug; 24(32):6049-6053. PubMed ID: 35938947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel rat lipoxin A4 receptor that is conserved in structure and function.
    Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
    Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
    J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
    Pierdomenico AM; Recchiuti A; Simiele F; Codagnone M; Mari VC; Davì G; Romano M
    J Biol Chem; 2015 Feb; 290(6):3592-600. PubMed ID: 25505240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.
    Devchand PR; Arita M; Hong S; Bannenberg G; Moussignac RL; Gronert K; Serhan CN
    FASEB J; 2003 Apr; 17(6):652-9. PubMed ID: 12665478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs.
    Sun YP; Tjonahen E; Keledjian R; Zhu M; Yang R; Recchiuti A; Pillai PS; Petasis NA; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):357-66. PubMed ID: 19853429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
    Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
    J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949.
    Stalder AK; Lott D; Strasser DS; Cruz HG; Krause A; Groenen PM; Dingemanse J
    Br J Clin Pharmacol; 2017 Mar; 83(3):476-486. PubMed ID: 27730665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ; Park MK; Lee EJ; Lee CH
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
    Colby JK; Gott KM; Wilder JA; Levy BD
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
    Forsman H; Önnheim K; Andreasson E; Dahlgren C
    Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.
    Waechter V; Schmid M; Herova M; Weber A; Günther V; Marti-Jaun J; Wüst S; Rösinger M; Gemperle C; Hersberger M
    J Immunol; 2012 Feb; 188(4):1856-67. PubMed ID: 22246625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.